AngioDynamics Inc
ANGO13.100USD
-0.060-0.46%
收盘 12/26, 16:00（美东）报价延迟15分钟
542.95M总市值
亏损市盈率 TTM
关于 AngioDynamics Inc 公司
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
AngioDynamics Inc简介
公司代码ANGO
公司名称AngioDynamics Inc
上市日期May 27, 2004
CEOClemmer (James C)
员工数量675
证券类型Ordinary Share
年结日May 27
公司地址14 Plaza Drive
城市LATHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编12110
电话15187981215
网址https://www.angiodynamics.com/
公司代码ANGO
上市日期May 27, 2004
CEOClemmer (James C)
AngioDynamics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-26.11%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Ms. Lorinda A. Burgess
Ms. Lorinda A. Burgess
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-26.11%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
United States
66.46M
87.78%
International
9.26M
12.22%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Divisadero Street Capital Management, LP
8.93%
BlackRock Institutional Trust Company, N.A.
7.05%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.74%
其他
65.84%
持股股东
持股股东
占比
Divisadero Street Capital Management, LP
8.93%
BlackRock Institutional Trust Company, N.A.
7.05%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.74%
其他
65.84%
股东类型
持股股东
占比
Investment Advisor
36.53%
Investment Advisor/Hedge Fund
35.68%
Hedge Fund
21.31%
Individual Investor
6.44%
Research Firm
1.99%
Pension Fund
1.68%
Bank and Trust
0.25%
Venture Capital
0.06%
Insurance Company
0.03%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
311
40.19M
106.71%
-10.46K
2025Q3
344
40.20M
109.06%
+1.51M
2025Q2
370
37.97M
110.38%
+1.85M
2025Q1
372
36.50M
106.59%
-6.63M
2024Q4
361
34.34M
98.76%
+1.35M
2024Q3
371
33.44M
109.60%
-216.03K
2024Q2
370
33.66M
118.59%
-3.23M
2024Q1
368
36.03M
115.74%
-10.10M
2023Q4
378
37.01M
114.23%
+355.36K
2023Q3
364
36.64M
109.90%
-219.51K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Divisadero Street Capital Management, LP
3.40M
8.24%
+2.44M
+253.67%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.96M
7.2%
-94.58K
-3.09%
Jun 30, 2025
Systematic Financial Management, L.P.
2.51M
6.09%
+12.62K
+0.51%
Jun 30, 2025
Point72 Asset Management, L.P.
1.95M
4.73%
+1.02M
+109.86%
Jun 30, 2025
The Vanguard Group, Inc.
2.49M
6.04%
-3.33K
-0.13%
Jun 30, 2025
Millennium Management LLC
2.15M
5.21%
+746.42K
+53.34%
Jul 16, 2025
Armistice Capital LLC
1.53M
3.71%
-566.18K
-27.04%
Jun 30, 2025
Segall Bryant & Hamill, LLC
1.36M
3.29%
-27.75K
-2.00%
Jun 30, 2025
Bastion Asset Management Inc.
959.04K
2.33%
+304.22K
+46.46%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.17M
2.85%
+7.01K
+0.60%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
State Street SPDR S&P Health Care Equipment ETF
0.79%
Invesco NASDAQ Future Gen 200 ETF
0.63%
Vanguard US Multifactor ETF
0.15%
iShares Micro-Cap ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.06%
Avantis US Small Cap Equity ETF
0.06%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
iShares Russell 2000 Value ETF
0.02%
查看更多
State Street SPDR S&P Health Care Equipment ETF
占比0.79%
Invesco NASDAQ Future Gen 200 ETF
占比0.63%
Vanguard US Multifactor ETF
占比0.15%
iShares Micro-Cap ETF
占比0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.07%
Fidelity Enhanced Small Cap ETF
占比0.06%
Avantis US Small Cap Equity ETF
占比0.06%
Invesco RAFI US 1500 Small-Mid ETF
占比0.04%
iShares Russell 2000 Value ETF
占比0.02%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
AngioDynamics Inc的前五大股东是谁？
AngioDynamics Inc 的前五大股东如下：
Divisadero Street Capital Management, LP持有股份：3.40M，占总股份比例：8.24%。
BlackRock Institutional Trust Company, N.A.持有股份：2.96M，占总股份比例：7.20%。
Systematic Financial Management, L.P.持有股份：2.51M，占总股份比例：6.09%。
Point72 Asset Management, L.P.持有股份：1.95M，占总股份比例：4.73%。
The Vanguard Group, Inc.持有股份：2.49M，占总股份比例：6.04%。
Divisadero Street Capital Management, LP持有股份：3.40M，占总股份比例：8.24%。
BlackRock Institutional Trust Company, N.A.持有股份：2.96M，占总股份比例：7.20%。
Systematic Financial Management, L.P.持有股份：2.51M，占总股份比例：6.09%。
Point72 Asset Management, L.P.持有股份：1.95M，占总股份比例：4.73%。
The Vanguard Group, Inc.持有股份：2.49M，占总股份比例：6.04%。
AngioDynamics Inc的前三大股东类型是什么？
AngioDynamics Inc 的前三大股东类型分别是：
Divisadero Street Capital Management, LP
BlackRock Institutional Trust Company, N.A.
Systematic Financial Management, L.P.
Divisadero Street Capital Management, LP
BlackRock Institutional Trust Company, N.A.
Systematic Financial Management, L.P.
有多少机构持有AngioDynamics Inc(ANGO)的股份？
截至2025Q4，共有311家机构持有AngioDynamics Inc的股份，合计持有的股份价值约为40.19M，占公司总股份的106.71%。与2025Q3相比，机构持股有所增加，增幅为-2.34%。
哪个业务部门对AngioDynamics Inc的收入贡献最大？
在FY2026Q1，--业务部门对AngioDynamics Inc的收入贡献最大，创收--，占总收入的--%。
